<DOC>
	<DOCNO>NCT02306577</DOCNO>
	<brief_summary>The SINNR study evaluate virologic efficacy ( viral load &lt; 50 copies/mL ) safety STRIBILD administer 48 week HIV-infected current recent illicit drug user .</brief_summary>
	<brief_title>STRIBILD Non-Nucleoside Resistant Patients ( SINNR STUDY )</brief_title>
	<detailed_description>The SINNR study pilot , observational , open label study . It evaluate virologic efficacy ( viral load &lt; 50 copies/mL ) , safety , immunologic response STRIBILD administer 48 week HIV-infected current recent illicit drug user . Approximately 30 HIV-infected current recent illicit drug user ( â‰¥19y.o. , &lt; 70y.o . ) Vancouver Infectious Diseases Centre Regina General Hospital , University Saskatchewan take oral 1 STRIBILD tablet day 48 week . Additionally , adherence STRIBILD 48 week quality life measure population .</detailed_description>
	<mesh_term>Elvitegravir , Cobicistat , Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<criteria>1 . Participant least 19 year age less 70 year age infect HIV require antiretroviral therapy medical ground acquire HIV infection illicit drug use . 2 . Participant document resistance NNRTIs , presence one primary resistance mutation ( Stanford database ) , current previous therapy . 3 . The primary care provider decide prescribe STRIBILD . 4 . Participant ongoing issue would lead significant noncompliance study procedure even presence optimal adherence support structure . 5 . Participant able read write language questionnaire give inform consent . 6 . Participant must take medication could interact STRIBILD . 7 . If female , participant must negative pregnancy test agree use , duration study , method birth control history prove reliability judge investigator . 1 . Participant previous exposure STRIBILD . 2 . Participant document resistance component STRIBILD . 3 . Participant pregnant breastfeeding . 4 . Participant contraindication use STRIBILD reason . 5 . Participant active hepatitis B ( HbsAg positive ) . 6 . Participant follow abnormal laboratory test result screen : Hemoglobin le 10.0 g/dL , Absolute neutrophil count le 750 cells/mL , Platelet count less 50,000/mL , ALT AST le 5x Upper Limit Normal ( ULN ) , Creatinine le 1.5 x ULN . 7 . Participant , opinion principal investigator , unlikely comply study protocol unsuitable reason .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>STRIBILD</keyword>
	<keyword>HIV</keyword>
	<keyword>Illicit dgug user</keyword>
</DOC>